Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) Change in Receivables: 2017-2020

Historic Change in Receivables for Cogent Biosciences (COGT) over the last 3 years, with Mar 2020 value amounting to -$2.0 million.

  • Cogent Biosciences' Change in Receivables fell 637.63% to -$2.0 million in Q1 2020 from the same period last year, while for Mar 2020 it was -$2.0 million, marking a year-over-year decrease of 564.69%. This contributed to the annual value of -$2.0 million for FY2020, which is 702.41% down from last year.
  • Cogent Biosciences' Change in Receivables amounted to -$2.0 million in Q1 2020, which was down 278.57% from $1.1 million recorded in Q4 2019.
  • Cogent Biosciences' Change in Receivables' 5-year high stood at $1.1 million during Q4 2019, with a 5-year trough of -$2.0 million in Q1 2020.
  • For the 3-year period, Cogent Biosciences' Change in Receivables averaged around -$92,222, with its median value being $217,000 (2018).
  • Its Change in Receivables has fluctuated over the past 5 years, first spiked by 1,980.49% in 2018, then plummeted by 637.63% in 2020.
  • Quarterly analysis of 4 years shows Cogent Biosciences' Change in Receivables stood at -$681,000 in 2017, then soared by 136.56% to $249,000 in 2018, then soared by 349.80% to $1.1 million in 2019, then crashed by 637.63% to -$2.0 million in 2020.
  • Its Change in Receivables was -$2.0 million in Q1 2020, compared to $1.1 million in Q4 2019 and -$612,000 in Q3 2019.